Literature DB >> 17480151

Serratia marcescens bacteremia - an indicator for outbreak management and heightened surveillance.

Elizabeth E Gillespie1, Jennifer Bradford, Judith Brett, Despina Kotsanas.   

Abstract

Colonization of neonatal intensive care units by Serratia marcescens is associated with clinical outbreaks. We report the management of an outbreak in a newborn services unit (NBS), in 2004, of a strain of S. marcescens that was present in the unit from 1994. Over the 10-year period, increases in clinical isolates demonstrated three epidemic curves, each spanning 3-4 years and each involving positive blood cultures. In 2004, clinical isolates of S. marcescens bacteremia prompted an investigation. Control measures including screening, creation of a separate unit, use of contact precautions, education, environmental sampling, strategies to reduce overcrowding, surveillance and molecular epidemiological techniques were implemented. In total, 99 babies were either colonized or infected with S. marcescens between December 2003 and December 2005. Isolates were tested with ribotyping identifying one main endemic strain. No environmental source was found, however, the outbreak terminated following adherence to infection control principles. Epidemiological information, structural and practice changes were used to prevent transmission and control the outbreak.

Entities:  

Mesh:

Year:  2007        PMID: 17480151     DOI: 10.1515/JPM.2007.043

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  2 in total

Review 1.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

2.  Management and investigation of a Serratia marcescens outbreak in a neonatal unit in Switzerland - the role of hand hygiene and whole genome sequencing.

Authors:  Walter Zingg; Isabelle Soulake; Damien Baud; Benedikt Huttner; Riccardo Pfister; Gesuele Renzi; Didier Pittet; Jacques Schrenzel; Patrice Francois
Journal:  Antimicrob Resist Infect Control       Date:  2017-12-11       Impact factor: 4.887

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.